Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, November 2001, p. 3213-3215, Vol. 45, No. 11
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.11.3213-3215.2001
Genetic Analysis of Multiple Loci Suggests that Mutations in
the Pneumocystis carinii f. sp.
hominis Dihydropteroate Synthase Gene Arose
Independently in Multiple Strains
Liang
Ma* and
Joseph A.
Kovacs
Critical Care Medicine Department, Warren
Grant Magnuson Clinical Center, National Institutes of Health,
Bethesda, Maryland
Received 9 April 2001/Returned for modification 16 May
2001/Accepted 30 July 2001
 |
ABSTRACT |
To determine if mutations in the dihydropteroate synthase (DHPS)
gene of Pneumocystis carinii f. sp.
hominis arose in a single strain that was subsequently
widely disseminated, we examined four genomic regions of 22 P.
carinii clinical isolates selected based on the absence or
presence of mutations in the DHPS gene. By single-strand conformation
polymorphism and DNA sequencing, we found varying genotypes for each of
the four regions in isolates with DHPS mutations, suggesting that
these mutations occurred independently in multiple strains of
P. carinii. This suggests that exposure to sulfa will
select for these mutations in diverse strains.
 |
TEXT |
Mutations in the human-derived
Pneumocystis carinii (P. carinii f. sp.
hominis) dihydropteroate synthase (DHPS) gene, the target of
sulfa drugs, have been reported with increasing frequency in the United
States (1, 4-6, 8, 11-13), Europe (3, 16), and Asia (15) and have been linked to prior exposure to
sulfa or dapsone, suggesting the possible emergence of sulfa
resistance. Epidemiological studies suggest that these mutations do not
represent allelic variants since they were rarely detected in clinical
isolates from the early 1980s (3, 16). The localization of
these mutations to two sites encoding amino acids in the active site of
the enzyme raises the possibility that these mutations arose in single
or limited numbers of P. carinii isolates that then became
widely disseminated. Alternatively, these mutations may have arisen
independently in multiple isolates, and due to their precise location,
conferred a survival advantage over wild-type strains or those strains
with other random mutations in the DHPS gene. To differentiate between these two mechanisms, we undertook to examine genomic loci with known
allelic variation in clinical P. carinii isolates with or without DHPS mutations.
(This work was presented in part at the 7th International Workshops on
Opportunistic Protists, Cincinnati, Ohio, 13 to 16 June 2001 [L. Ma
and J. A. Kovacs, Abstr. 7th Int. Workshops Opportunistic Protists,
abstr. PO16, 2001].)
We used a previously described PCR-single-strand conformation
polymorphism (SSCP) technique (2, 12) to analyze four
genomic regions, including the intron of the nuclear 26S rRNA gene (26S rRNA), the internal transcribed spacer 1 of the nuclear rRNA gene operon (ITS1), the variable region of the mitochondrial 26S rRNA gene
(mt26S), and the intron 6 region of the
-tubulin gene (tubulin). Twenty-two isolates (2 autopsy lung samples, 7 sputum samples, and 13 bronchoalveolar lavage fluid samples) were obtained from patients
diagnosed with P. carinii pneumonia between 1986 and 1999. The DHPS gene in these isolates had been typed previously by DNA
sequencing and/or SSCP (11, 12). Genomic DNA was extracted either by treatment with proteinase K followed by phenol-chloroform extraction as described previously (11) or by use of the
NucliSens isolation kit (Organon Teknika, Durham, N.C.). Two
microliters of DNA extract was added to a 20-µl PCR mixture
containing 0.25 µM concentrations of each primer, 10 mM Tris-HCl (pH
8.3), 50 mM KCl, 2.5 mM MgCl2, 0.2 mM
deoxynucleoside triphosphates, and 2.5 U of AmpliTaq Gold DNA
polymerase (Perkin Elmer, Foster City, Calif.). The primers and the
thermal cycling conditions used for amplification of the four variable
regions were identical to those described by Hauser et al.
(2). After examination by electrophoresis on a 3% NuSieve
3:1 agarose gel (FMC Bioproducts, Rockland, Maine), 2- to 2.5-µl
aliquots of PCR products were analyzed by SSCP using the GenePhor
Electrophoresis System, a precast GeneGel SSCP gel, and GeneGel SSCP
Buffer (Amersham Pharmacia Biotech, San Francisco, Calif.) as described
previously (12). The optimal electrophoretic buffer,
temperature, and migration time for each genomic locus were as follows:
ITS1, buffer B, 12°C, 270 min; 26S rRNA, buffer C, 12°C, 185 min;
mt26S, buffer C, 5°C, 260 min; tubulin, buffer A, 12°C, 190 min.
These conditions were optimized for our laboratory and varied from
those described previously (2). The gels were stained by
using the PlusOne DNA silver staining kit (Amersham Pharmacia Biotech).
The SSCP patterns for four genomic loci in 22 clinical isolates are
shown in Fig. 1. Although the DNA
fragments examined in this study are the same as those reported by
Hauser et al. (2), the SSCP patterns differ from those in
the earlier report, especially for ITS1 and mt26S. This is most likely
due to the different electrophoretic conditions. In this study, we
found two different SSCP patterns, representing two different
genotypes, for the 26S rRNA and
-tubulin loci, respectively. The
SSCP patterns for the ITS1 and mt26S loci showed great variability,
with at least four different patterns.

View larger version (92K):
[in this window]
[in a new window]
|
FIG. 1.
SSCP analysis of four genomic loci (indicated at the
left) for P. carinii f. sp. hominis
isolates. Mixture represents either wild-type and double mutation
(A/T-55 and S/P-57) or single A-55 mutation and double mutation (A-55
and S/P-57). The DHPS genotype is indicated at the top. Patient numbers
(1 to 22) are shown under the DHPS genotypes. Below each lane is the
genotype for each locus. The genotypes for 26S rRNA and tubulin were
named based on SSCP patterns alone, and the genotypes for ITS1 and
mt26S were determined by SSCP analysis combined with DNA sequencing.
Undetermined genotypes are indicated by " ." The genotypes for
ITS1 correspond to those described previously (9), with
the variable numbers of T at positions 62 to 71 given in superscript
(" 1" and "+1" represent 9 and 11 T's, respectively, compared
to the commonly seen 10 T's). For mt26S, all five genotypes contain a
G-to-A change at position 288 compared to the published sequenced
(14), with an additional C-to-A change at position 85, a
C-to-T change at position 248, a C-to-T change at position 85, or a
C-to-T change at position 80 in types 2,
3, 4, and 5,
respectively.
|
|
To more accurately determine the genotypes for ITS1 and mt26S, for
selected isolates we performed direct sequencing and/or sequencing of
individual clones after subcloning of PCR products. Sequencing of the
ITS1 region of 20 isolates revealed nucleotide variations at seven
positions (6, 14, 15, 21, 28, 80, and 81) which were identical to those
reported by Lee at al. (9). In addition, for 10 isolates
we observed variable numbers of the nucleotide T in a poly(T) tract at
positions 62 to 71, as previously described (9). By
sequencing of individual clones after subcloning, two isolates (no. 3 and 12) were found to contain two types of ITS1 sequence. For two
isolates (no. 20 and 21), direct sequencing was unsuccessful and the
ITS1 genotypes could not be accurately determined by SSCP alone. Among
the 20 isolates sequenced, there were five types of ITS1 sequences,
excluding variation in the T's in positions 62 to 71. The ITS1
genotype for each isolate was assigned as described previously
(9). Sequencing of the mt26S sequences of 12 isolates
revealed four genotypes with nucleotide variations at positions 85, 248, and 288 as described previously (7, 10, 14). A novel
genotype with a C-to-T change at position 80 was identified for one
isolate (no. 5) by three separate PCRs followed by direct sequencing.
The genotypes of unsequenced isolates were determined by comparing the
SSCP patterns to those of the sequenced isolates. For two isolates (no.
20 and 22), the mt26S genotypes could not be accurately determined.
Based on the DHPS sequences, the 22 isolates were divided into four
groups, including 5 wild-type isolates (Thr-55 and Pro-57), 7 single
Ala-55 mutants, 7 double mutants (Ala-55 and Ser-57), and 3 mixtures of
either wild-type and double mutation (Ala/Thr-55 and Ser/Pro-57) or
single Ala-55 mutation and double mutation (Ala-55 and Ser/Pro-57). As
shown in Fig. 1, each group had a mixture of genotypes for each of the
four genomic loci. The variability in ITS1 and mt26S was greater than
that in 26S rRNA and tubulin. Among the 14 isolates containing either
single Ala-55 or double mutations, there were 10 unique types based on
analysis of these four loci (Table 1).
When taking into account the variable numbers of T at positions 62 to
71, there was one additional type. These observations strongly suggest
that DHPS mutations did not arise from a single strain of P. carinii, but rather that they arose independently in multiple
different strains. Thus, while mutations may randomly occur in the DHPS
gene (presumably at a low frequency), mutations at codons 55 and 57 are
likely to confer a selective survival advantage to P. carinii during exposure to sulfa drugs. Nevertheless, an
alternative explanation is that these mutations arose in single or
limited numbers of P. carinii isolates that then became
widely disseminated, with the complexity of genetic types resulting
from horizontal transfer of DNA during sexual reproduction or another
mechanism.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Typing of 14 P. carinii f. sp.
hominis isolates with either single or double DHPS
mutations, based on analysis of four genetic loci
|
|
 |
ACKNOWLEDGMENTS |
We thank Steven R. Meshnick, Department of Epidemiology, School of
Public Health, University of Michigan, Ann Arbor, Mich., for his
suggestions to initiate this study.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Building 10, Room 7D43, National Institutes of Health, 10 Center Dr. MSC 1662, Bethesda, MD 20892-1662. Phone: (301) 435-2301. Fax: (301) 402-1213. E-mail: LMa{at}nih.gov
 |
REFERENCES |
| 1.
|
Beard, C. B.,
J. L. Carter,
S. P. Keely,
L. Huang,
N. J. Pieniazek,
I. N. Moura,
J. M. Roberts,
A. W. Hightower,
M. S. Bens,
A. R. Freeman,
S. Lee,
J. R. Stringer,
J. S. Duchin,
C. del Rio,
D. Rimland,
R. P. Baughman,
D. A. Levy,
V. J. Dietz,
P. Simon, and T. R. Navin.
2000.
Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission.
Emerg. Infect. Dis.
6:265-272[Medline].
|
| 2.
|
Hauser, P. M.,
P. Francioli,
J. Bille,
A. Telenti, and D. S. Blanc.
1997.
Typing of Pneumocystis carinii f. sp. hominis by single-strand conformation polymorphism of four genomic regions.
J. Clin. Microbiol.
35:3086-3091[Abstract].
|
| 3.
|
Helweg-Larsen, J.,
T. L. Benfield,
J. Eugen-Olsen,
J. D. Lundgren, and B. Lundgren.
1999.
Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.
Lancet
354:1347-1351[CrossRef][Medline].
|
| 4.
|
Huang, L.,
C. B. Beard,
J. Creasman,
D. Levy,
J. S. Duchin,
S. Lee,
N. Pieniazek,
J. L. Carter,
C. del Rio,
D. Rimland, and T. R. Navin.
2000.
Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene.
J. Infect. Dis.
182:1192-1198[CrossRef][Medline].
|
| 5.
|
Kazanjian, P.,
W. Armstrong,
P. A. Hossler,
W. Burman,
J. Richardson,
C. H. Lee,
L. Crane,
J. Katz, and S. R. Meshnick.
2000.
Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients.
J. Infect. Dis.
182:551-557[CrossRef][Medline].
|
| 6.
|
Kazanjian, P.,
A. B. Locke,
P. A. Hossler,
B. R. Lane,
M. S. Bartlett,
J. W. Smith,
M. Cannon, and S. R. Meshnick.
1998.
Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.
AIDS
12:873-878[CrossRef][Medline].
|
| 7.
|
Keely, S. P., and J. R. Stringer.
1997.
Sequences of Pneumocystis carinii f. sp. hominis strains associated with recurrent pneumonia vary at multiple loci.
J. Clin. Microbiol.
35:2745-2747[Abstract].
|
| 8.
|
Lane, B. R.,
J. C. Ast,
P. A. Hossler,
D. P. Mindell,
M. S. Bartlett,
J. W. Smith, and S. R. Meshnick.
1997.
Dihydropteroate synthase polymorphisms in Pneumocystis carinii.
J. Infect. Dis.
175:482-485[Medline].
|
| 9.
|
Lee, C. H.,
J. Helweg-Larsen,
X. Tang,
S. Jin,
B. Li,
M. S. Bartlett,
J. J. Lu,
B. Lundgren,
J. D. Lundgren,
M. Olsson,
S. B. Lucas,
P. Roux,
A. Cargnel,
C. Atzori,
O. Matos, and J. W. Smith.
1998.
Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes.
J. Clin. Microbiol.
36:734-741[Abstract/Free Full Text].
|
| 10.
|
Lee, C. H.,
J. J. Lu,
M. S. Bartlett,
M. M. Durkin,
T. H. Liu,
J. Wang,
B. Jiang, and J. W. Smith.
1993.
Nucleotide sequence variation in Pneumocystis carinii strains that infect humans.
J. Clin. Microbiol.
31:754-757[Abstract/Free Full Text].
|
| 11.
|
Ma, L.,
L. Borio,
H. Masur, and J. A. Kovacs.
1999.
Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
J. Infect. Dis.
180:1969-1978[CrossRef][Medline].
|
| 12.
|
Ma, L., and J. A. Kovacs.
2001.
Rapid detection of mutations in the human-derived Pneumocystis carinii dihydropteroate synthase gene associated with sulfa resistance.
Antimicrob. Agents Chemother.
45:776-780[Abstract/Free Full Text].
|
| 13.
|
Mei, Q.,
S. Gurunathan,
H. Masur, and J. A. Kovacs.
1998.
Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene.
Lancet
351:1631-1632[Medline].
|
| 14.
|
Sinclair, K.,
A. E. Wakefield,
S. Banerji, and J. M. Hopkin.
1991.
Pneumocystis carinii organisms derived from rat and human hosts are genetically distinct.
Mol. Biochem. Parasitol.
45:183-184[CrossRef][Medline].
|
| 15.
|
Takahashi, T.,
N. Hosoya,
T. Endo,
T. Nakamura,
H. Sakashita,
K. Kimura,
K. Ohnishi,
Y. Nakamura, and A. Iwamoto.
2000.
Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy.
J. Clin. Microbiol.
38:3161-3164[Abstract/Free Full Text].
|
| 16.
|
Visconti, E.,
E. Ortona,
P. Margutti,
S. Marinaci,
M. Zolfo,
P. Mencarini,
L. P. Celentano,
A. Siracusano, and E. Tamburrini.
1999.
Identification of dihydropteroate (DHPS) gene mutant in Pneumocystis carinii in respiratory samples of HIV positive patients from 1992 to 1997.
J. Eukaryot. Microbiol.
46:132S[Medline].
|
Antimicrobial Agents and Chemotherapy, November 2001, p. 3213-3215, Vol. 45, No. 11
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.11.3213-3215.2001
This article has been cited by other articles:
-
Iliades, P., Meshnick, S. R., Macreadie, I. G.
(2004). Dihydropteroate Synthase Mutations in Pneumocystis jiroveci Can Affect Sulfamethoxazole Resistance in a Saccharomyces cerevisiae Model. Antimicrob. Agents Chemother.
48: 2617-2623
[Abstract]
[Full Text]
-
Totet, A., Duwat, H., Magois, E., Jounieaux, V., Roux, P., Raccurt, C., Nevez, G.
(2004). Similar genotypes of Pneumocystis jirovecii in different forms of Pneumocystis infection. Microbiology
150: 1173-1178
[Abstract]
[Full Text]